BOUT vs. HELX ETF Comparison
Comparison of Innovator IBD Breakout Opportunities ETF (BOUT) to Franklin Genomic Advancements ETF (HELX)
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.
Grade (RS Rating)
Last Trade
$34.17
Average Daily Volume
2,160
59
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$30.13
Average Daily Volume
668
55
Performance
| Period | BOUT | HELX |
|---|---|---|
| 30 Days | -5.96% | -8.14% |
| 60 Days | -2.74% | -6.81% |
| 90 Days | 3.52% | 0.55% |
| 12 Months | 13.70% | 2.42% |
0 Overlapping Holdings
| Symbol | Grade | Weight in BOUT | Weight in HELX | Overlap |
|---|
BOUT Overweight 59 Positions Relative to HELX
| Symbol | Grade | Weight | |
|---|---|---|---|
| FTI | A | 3.47% | |
| KSPI | A | 3.34% | |
| AZEK | C | 3.2% | |
| MSDL | A | 3.17% | |
| TBBB | B | 3.16% | |
| BLDR | C | 3.16% | |
| HEAR | B | 3.15% | |
| TXRH | A | 3.14% | |
| LEN | C | 3.13% | |
| WING | A | 3.09% | |
| HUBS | B | 2.97% | |
| GPS | C | 2.84% | |
| IBKR | A | 2.8% | |
| CELH | C | 2.8% | |
| XYL | A | 2.75% | |
| JPM | B | 2.73% | |
| SAP | C | 2.72% | |
| FROG | C | 2.7% | |
| DUOL | B | 2.7% | |
| PCOR | D | 2.63% | |
| APPF | B | 2.61% | |
| IOT | B | 2.48% | |
| GOOGL | A | 1.87% | |
| GOOG | A | 1.87% | |
| CRM | D | 1.85% | |
| PCAR | D | 1.82% | |
| RCL | A | 1.81% | |
| IRM | B | 1.81% | |
| SHAK | B | 1.8% | |
| FOR | D | 1.8% | |
| AXP | A | 1.8% | |
| ERJ | A | 1.77% | |
| CROX | C | 1.72% | |
| SEMR | C | 0.93% | |
| PWR | A | 0.93% | |
| NTAP | A | 0.93% | |
| GVA | A | 0.92% | |
| ERIE | C | 0.92% | |
| URI | B | 0.91% | |
| TOL | B | 0.89% | |
| ISRG | C | 0.89% | |
| RL | C | 0.85% | |
| KNSL | F | 0.78% | |
| ELF | C | 0.76% | |
| WAB | A | 0.35% | |
| SKWD | D | 0.35% | |
| PSTG | A | 0.35% | |
| NVDA | B | 0.35% | |
| ANET | C | 0.35% | |
| WMS | C | 0.34% | |
| PLTR | C | 0.34% | |
| KKR | C | 0.34% | |
| OKTA | D | 0.33% | |
| LRN | B | 0.33% | |
| FIHL | A | 0.33% | |
| DFH | C | 0.33% | |
| ASML | C | 0.33% | |
| TREX | C | 0.32% | |
| RYAN | D | 0.32% |
BOUT Underweight 55 Positions Relative to HELX
| Symbol | Grade | Weight | |
|---|---|---|---|
| MEDP | C | -7.62% | |
| TMO | B | -4.75% | |
| VRTX | C | -4.72% | |
| REGN | D | -4.59% | |
| KRYS | D | -4.35% | |
| LLY | D | -4.34% | |
| DHR | C | -4.09% | |
| BRKR | D | -3.27% | |
| NTRA | A | -2.99% | |
| AZN | A | -2.51% | |
| CRL | D | -2.42% | |
| CDNS | D | -2.35% | |
| IONS | D | -2.32% | |
| CTVA | C | -2.19% | |
| A | C | -2.17% | |
| RCKT | F | -2.14% | |
| MRNA | B | -2.03% | |
| EXAS | F | -1.99% | |
| QGEN | D | -1.81% | |
| BNTX | F | -1.71% | |
| SRPT | B | -1.57% | |
| ICLR | C | -1.52% | |
| FDMT | D | -1.4% | |
| ALNY | F | -1.33% | |
| NTLA | F | -1.25% | |
| IQV | C | -1.17% | |
| VYGR | F | -1.14% | |
| AZTA | D | -1.07% | |
| RARE | C | -1.0% | |
| RGEN | D | -1.0% | |
| LH | F | -0.96% | |
| TECH | D | -0.87% | |
| CRSP | F | -0.8% | |
| INSM | F | -0.79% | |
| NBIX | C | -0.78% | |
| BMY | F | -0.73% | |
| LGND | D | -0.7% | |
| TWST | C | -0.67% | |
| BEAM | F | -0.66% | |
| BIO | F | -0.66% | |
| BBIO | F | -0.57% | |
| CDMO | D | -0.57% | |
| SDGR | F | -0.53% | |
| AVTR | D | -0.52% | |
| UTHR | B | -0.51% | |
| DVAX | F | -0.49% | |
| SLP | B | -0.42% | |
| RXRX | F | -0.36% | |
| ARE | D | -0.31% | |
| DOCS | F | -0.3% | |
| FTRE | D | -0.18% | |
| VCYT | F | -0.14% | |
| OLK | C | -0.12% | |
| TXG | F | -0.11% | |
| PACB | F | -0.04% |
BOUT: Top Represented Industries & Keywords
HELX: Top Represented Industries & Keywords
Compare ETFs
